COMMUNIQUÉS West-GlobeNewswire

ORION CORPORATION: ACQUISITION OF OWN SHARES 07.05.2019

07/05/2019 - 17:30

Orion Corporation NOTIFICATION 07.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 07.05.2019 Date 07.05.2019 Exchange transaction Buy Share class ORNBV Amount 30,832 Average price/share 29.6153 EUR Highest [...]

Dermatologists Say Sunscreen is a Vital Tool in the Fight Against Skin Cancer, the Most Common Cancer in the U.S.; American Academy of Dermatology

07/05/2019 - 17:30

During Skin Cancer Awareness Month, the American Academy of Dermatology is asking the public “Do you use protection?” and encouraging consumers to “practice safe sun” — which includes applying sunscreen ROSEMONT, Ill., [...]

Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association

07/05/2019 - 17:19

Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association Switzerland, May 7, 2019: Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today [...]

Nelipak Healthcare Packaging and OPTEL Partner to Demonstrate New Seal Inspection Technology Concept for Vacuum-Formed Trays at MedtecLIVE 2019

07/05/2019 - 17:19

CRANSTON, R.I., May 07, 2019 (GLOBE NEWSWIRE) -- Nelipak ® Healthcare Packaging (“Nelipak”), a full-service global provider of custom thermoformed packaging that provides superior protection for medical devices and [...]

Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

07/05/2019 - 15:15

Top-line Data Readout on Target for early Q4 2019 LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative [...]

Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission

07/05/2019 - 15:01

Dupixent ® (dupilumab) Approved for Severe Asthma by European Commission Only biologic approved in the EU for severe asthma with type 2 inflammation, as characterized by raised blood eosinophils and/or raised fractional [...]

Sanofi : Dupixent® (dupilumab) approuvé dans le traitement de l'asthme sévère par la Commission européenne

07/05/2019 - 15:01

Dupixent ® (dupilumab) approuvé dans le traitement de l'asthme sévère par la Commission européenne Seul médicament biologique approuvé dans l'UE pour le traitement de l'asthme sévère avec inflammation de type 2 [...]

Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight Gain

07/05/2019 - 15:00

Hamilton, Bermuda, May 07, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]

CareDx’s AlloSeq cfDNA and QTYPE Solutions Featured at EFI 2019

07/05/2019 - 15:00

CareDx leadership in transplant innovation highlighted through multiple podium and poster presentations BRISBANE, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics [...]

CohBar Appoints Steven B. Engle as Chief Executive Officer

07/05/2019 - 15:00

MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy [...]

Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update

07/05/2019 - 15:00

SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various [...]

ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019

07/05/2019 - 15:00

Conference Call Scheduled for Tuesday, May 14, 2019 at 9:00 AM ET PORTLAND, Maine, May 07, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company [...]

TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis at the American Academy of Neurology 71st Annual Meeting

07/05/2019 - 15:00

Ublituximab treatment continues to be well tolerated with a median duration of follow-up of 97.5 weeks NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company [...]

Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and Patient-Clinician Conversations in Parkinson’s Disease

07/05/2019 - 15:00

Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON and MELBOURNE, [...]

Driven Deliveries Inc. to Present at The MoneyShow in Las Vegas On May 13th 2019

07/05/2019 - 14:50

Management will also participate in Panel Discussion. Investing in Cannabis SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (DRVD), the world’s first publicly traded cannabis delivery company, [...]

CV Sciences, Inc. to Present at Upcoming Investor Conferences

07/05/2019 - 14:45

LAS VEGAS, May 07, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating [...]

Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union

07/05/2019 - 14:41

WAYLIVRA is the only therapy for Familial Chylomicronemia Syndrome, or FCS, a devastating, ultra-rare disease BOSTON and CARLSBAD, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an [...]

OLAH Healthcare Technology Welcomes Chad Hill as Vice President of Operations

07/05/2019 - 14:38

COLUMBUS, Ohio, May 07, 2019 (GLOBE NEWSWIRE) -- On April 15, Chad Hill joined OLAH Healthcare Technology as Vice President of Operations, assuming responsibility for operational management of OLAH’s client services [...]

Better Choice Company Announces Closing of TruPet and Bona Vida Acquisitions

07/05/2019 - 14:32

The closing positions the Company with first-mover advantage within the pet CBD industry BROOKLYN, N.Y., May 07, 2019 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (OTCQB: BTTR) (the “Company”) today announced the [...]